| Patents for C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865) |
|---|
| 05/02/2002 | US20020052512 Diaminopropionic acid derivatives |
| 05/02/2002 | US20020052509 Calcilytic compounds and method of use |
| 05/02/2002 | US20020052496 Novel 1-(N'-(arylalkylaminoalkyl)) aminoisoquinolines: a new class of dopamine receptor subtype |
| 05/02/2002 | US20020052378 Novel compounds and compositions as protease inhibitors |
| 05/02/2002 | EP1200410A1 Isoquinoline derivatives, pharmaceutical compositions containing the same, and a process for the preparation of the active substance |
| 05/02/2002 | EP1200409A2 Substituted isoquinoline derivatives and their use as anticonvulsants |
| 05/02/2002 | EP1200407A1 Reductive methylation of tetrahydroisochinoline in a static micromixer |
| 05/02/2002 | EP1200397A1 Sulfonamide substituted benzylamine derivatives and their use as medicaments |
| 05/02/2002 | EP1200375A2 Nitration in a static micromixer |
| 05/02/2002 | EP1015432B1 Separation of enantiomers of octahydroisoquinoline |
| 05/02/2002 | EP0615448B1 Sex steroid activity inhibitors |
| 04/30/2002 | US6380258 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
| 04/30/2002 | US6380211 For treating diabetes |
| 04/30/2002 | US6380188 For inhibiting human immunodeficiency virus protease |
| 04/25/2002 | WO2002032864A1 Pharmaceutically active sulfanilide derivatives |
| 04/25/2002 | US20020049337 4-(2-amino-1-hydroxyethyl)oxazoline derivative and method for producing same |
| 04/25/2002 | US20020049226 Treating obesity, hyperlipidemia, glaucoma, arrhythmia, skin disorders, thyroid disease, hypothyroidism, diabetes mellitus, atherosclerosis, hypertension, coronary heart disease, hypercholesteremia, depression and osteoporosis |
| 04/25/2002 | US20020049222 Cyclopentyl modulators of chemokine receptor activity |
| 04/25/2002 | US20020049193 Inhibitors of the enzyme activity associated with immunophilin proteins, particularly peptidyl-prolyl isomerase, or rotamase, enzyme activity. |
| 04/25/2002 | CA2423933A1 Pharmaceutically active sulfanilide derivatives |
| 04/23/2002 | US6376530 A n-methylaspartic acid antagonist; nervous system disorders, analgesics |
| 04/23/2002 | US6376515 Benzamides and related inhibitors of factor Xa |
| 04/23/2002 | US6376494 Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents |
| 04/18/2002 | WO2002030905A1 Method of preparation of (s)-n-tert-butyl-1,2,3,4-tetrahydroisoquinoline-3-carboxamide |
| 04/18/2002 | WO2002030888A2 Tricyclic compounds and uses thereof |
| 04/18/2002 | WO2002012166A3 Triamine derivative melanocortin receptor ligands and methods of using same |
| 04/18/2002 | WO2002002541A3 Inhibitors of copper-containing amine oxidases |
| 04/18/2002 | US20020045640 Anellated dihydropyridines for the treatment of chronic pain |
| 04/18/2002 | US20020045206 Contacting the cells with a trophic amount of a ptc therapeutic for promoting survival of substantia nigra neuronal cells |
| 04/18/2002 | CA2424292A1 Tricyclic compounds and uses thereof |
| 04/17/2002 | EP1196411A1 Bradykinin b1 receptor antagonists |
| 04/17/2002 | EP1196397A1 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases |
| 04/17/2002 | EP1196389A1 N-heterocyclic derivatives with neuronal activity |
| 04/17/2002 | EP1196379A2 INHIBITORS OF FACTOR Xa |
| 04/17/2002 | EP0854846B1 Method of resolving racemic mixtures |
| 04/17/2002 | CN1345308A Acetylenic alpha-amino acid based sulfonamide hydroxamic acid TACE inhibitors |
| 04/17/2002 | CN1345303A Oxamic acids and derivatives as thyroid receptor ligands |
| 04/11/2002 | WO2002028830A1 Novel phenylalanine derivatives |
| 04/11/2002 | WO2002028829A2 Peptide deformylase inhibitors |
| 04/11/2002 | WO2002028815A1 Pharmaceutical compounds |
| 04/11/2002 | WO2001090070A3 Caspase inhibitors and uses thereof |
| 04/11/2002 | WO2001085671A3 Anthranyl amides and their use as medicaments |
| 04/11/2002 | US20020042534 Method for producing an alpha-aminonitrile from a tertiary anime and a cyanide through oxidation with oxygen by using a transition metal catalyst |
| 04/11/2002 | CA2419777A1 Pharmaceutical compounds |
| 04/10/2002 | EP1194403A1 Indanyl-substituted benzole carbonamide, method for the production of the same, use thereof as a medicament and pharmaceutical preparations containing the same |
| 04/10/2002 | CN1344266A Novel compounds |
| 04/04/2002 | WO2002026727A2 Methods of providing and using compounds (retinoids) having activity as inhibitors of cytochrome p450rai |
| 04/04/2002 | WO2001085694A3 Substituted diamide derivatives useful as motilin antagonists |
| 04/04/2002 | WO2001064643A3 Benzamides and related inhibitors of factor xa |
| 04/04/2002 | US20020040144 For therapy of thrombotic disease, asthma, emphysema, cirrhosis, arthritis, carcinoma, melanoma, restenois, atheroma, trauma, shock and reperfusion injury |
| 04/04/2002 | US20020039998 Administering to human therapeutically effective amount of a combination of drug which is metabolized by cytochrome p450 monooxygenase or pharmaceutically acceptable salt thereof and ritonavir |
| 04/04/2002 | CA2423919A1 Methods of providing and using compounds (retinoids) having activity as inhibitors of cytochrome p450rai |
| 04/03/2002 | EP1193257A2 Compounds for ceramide-mediated signal transduction |
| 04/03/2002 | EP1192135A2 Serine protease inhibitors |
| 04/03/2002 | EP1192132A2 Serine protease inhibitors |
| 04/03/2002 | EP0898567B1 N-aminoalkyl-1-biphenylenyl-2-carboxamides; dopamine receptor subtype specific ligands |
| 04/02/2002 | US6365590 Compounds, compositions and methods for treating erectile dysfunction |
| 04/02/2002 | US6365587 Substituted aryl hydroxamic acids as metalloproteinase inhibitors |
| 04/02/2002 | CA2253906C Process for preparation of pyrimidine derivatives |
| 04/02/2002 | CA2223574C Biphenyl-2-carboxylic acid-tetrahydro-isoquinolin-6-yl amide derivatives, their preparation and their use as inhibitors of microsomal triglyceride transfer protein and/or apolipoprotein b (apo b) secretion |
| 03/28/2002 | WO2002025648A1 Optical data carrier containing a phthalocyanine colouring agent as a light absorbing compound in the information layer |
| 03/28/2002 | WO2002025205A1 Optical data storage device containing a co-phthalocyanin complex in the optically writable information layer |
| 03/28/2002 | WO2002024672A2 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases |
| 03/28/2002 | WO2002024655A1 Isoquinolinone potassium channel inhibitors |
| 03/28/2002 | WO2002024653A1 Compounds and methods for modulation of estrogen receptors |
| 03/28/2002 | WO2002024636A2 N-acylsulfonamide apoptosis promoters |
| 03/28/2002 | WO2002024635A2 Aminoalcohol derivatives |
| 03/28/2002 | US20020038033 Treating tetrahydrofuran derivativ with an oxophilic electrophilic reagent in a manner that is effective to provide the oxazoline compound |
| 03/28/2002 | US20020038027 Intermediates for making HIV-protease inhibitors and methods for making HIV-protease inhibitors |
| 03/28/2002 | US20020037909 Enamine derivatives |
| 03/28/2002 | US20020037897 Tetrahydroisoquinoline-3-carboxylic acid alkoxyguanidines as integrin antagonists |
| 03/28/2002 | US20020037885 Therapeutic compounds |
| 03/28/2002 | US20020037858 Pharmaceutical compositions comprising moexipril magnesium |
| 03/28/2002 | DE10046272A1 New biphenyl-substituted amino-(iso)quinoline derivatives, are factor Xa and factor VIIa inhibitors useful e.g. for treating thrombosis, myocardial infarction, inflammation, angina pectoris or restenosis |
| 03/28/2002 | CA2423106A1 Compounds and methods for modulation of estrogen receptors |
| 03/28/2002 | CA2416136A1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases |
| 03/27/2002 | EP1189882A1 Biphenyl butyric acid derivative as a matrix metalloproteinase inhibitor |
| 03/27/2002 | EP1189879A1 INHIBITORS OF FACTOR Xa |
| 03/27/2002 | EP1189612A1 Vla-4 inhibitor compounds |
| 03/26/2002 | US6362373 Chiral amino alcohols and process for preparation of same |
| 03/26/2002 | US6362193 Antiinflammatory agents |
| 03/21/2002 | WO2002022551A1 Derivatives of naphthalene with comt inhibiting activity |
| 03/21/2002 | WO2002022550A2 Chiral amino alcohols and process for preparation of same |
| 03/21/2002 | US20020035285 Hydrogenation catalyst |
| 03/20/2002 | EP1187531A1 Macrophage scavenger receptor antagonists |
| 03/20/2002 | EP0944590B1 Aminoguanidines and alkoxyguanidines as protease inhibitors |
| 03/20/2002 | CN1341095A Amide compounds for potentiation of cholinergic activity |
| 03/19/2002 | US6359135 Compounds having activity as inhibitors of cytochrome P450RAI |
| 03/19/2002 | US6358974 Used as as modulators of dopamine d.sub.3 receptors, in therapy as antipsychotic agents |
| 03/14/2002 | WO2002020465A2 Gamma-ketoacid dipeptides as inhibitors of caspase-3 |
| 03/14/2002 | US20020032326 Treating mammalian leukemia; lung carcinoma; colon adenocarcinoma malignant melanoma; assaying the human cytochrome CYP3A4 metabolism of ecteinascidin 743 |
| 03/14/2002 | DE10041402A1 Neue Verbindungen, die Faktor Xa-Aktivität inhibieren Novel compounds which inhibit factor Xa activity |
| 03/14/2002 | CA2421172A1 Gamma-ketoacid dipeptides as inhibitors of caspase-3 |
| 03/13/2002 | EP1185509A2 INHIBITORS OF FACTOR Xa |
| 03/13/2002 | EP1185508A2 Inhibitors of factor xa |
| 03/13/2002 | EP0802910B1 Estrogen agonists/antagonists |
| 03/12/2002 | US6355670 Skin disorders |
| 03/07/2002 | WO2002018361A2 Compounds having activity as inhibitors of cytochrome p450rai |
| 03/07/2002 | WO2002017712A2 Disubstituted benzenes as insecticides |
| 03/07/2002 | WO2001070684A3 Peptidomimetic ligands for cellular receptors and ion channels |